Hah Jennifer M, Mackey Sean, Barelka Peter L, Wang Charlie K M, Wang Bing M, Gillespie Matthew J, McCue Rebecca, Younger Jarred W, Trafton Jodie, Humphreys Keith, Goodman Stuart B, Dirbas Fredrick M, Schmidt Peter C, Carroll Ian R
Division of Pain Medicine, Stanford University, Palo Alto, California, USA.
Pain Med. 2014 Jun;15(6):954-64. doi: 10.1111/pme.12439.
We previously reported that increased preoperative Beck Depression Inventory II (BDI-II) scores were associated with a 47% (95% CI 24%-64%) reduction in the rate of opioid cessation following surgery. We aimed to identify the underlying factors of the BDI-II (affective/cognitive vs somatic) associated with a decreased rate of opioid cessation after surgery.
We conducted a secondary analysis of the data from a previously reported prospective, longitudinal, observational study of opioid use after five distinct surgical procedures (total hip replacement, total knee replacement, thoracotomy, mastectomy, and lumpectomy) in 107 patients. The primary endpoint was time to opioid cessation. After exploratory factor analysis of the BDI-II, mean summary scores were calculated for each identified factor. These scores were evaluated as predictors of time to opioid cessation using Cox proportional hazards regression.
The exploratory factor analysis produced three factors (self-loathing symptoms, motivational symptoms, emotional symptoms). All three factors were significant predictors in univariate analysis. Of the three identified factors of the BDI-II, only preoperative self-loathing symptoms (past failure, guilty feelings, self-dislike, self-criticalness, suicidal thoughts, worthlessness) independently predicted a significant decrease in opioid cessation rate after surgery in the multivariate analysis (HR 0.86, 95% CI 0.75-0.99, P value 0.037).
Our results identify a set of negative cognitions predicting prolonged time to postoperative opioid cessation. Somatic symptoms captured by the BDI-II were not primarily responsible for the association between preoperative BDI-II scores and postoperative prolonged opioid use.
我们之前报道过,术前贝克抑郁量表第二版(BDI-II)得分升高与术后阿片类药物停用率降低47%(95%置信区间24%-64%)相关。我们旨在确定与术后阿片类药物停用率降低相关的BDI-II潜在因素(情感/认知因素与躯体因素)。
我们对之前报道的一项前瞻性、纵向、观察性研究的数据进行了二次分析,该研究涉及107例患者接受的五种不同外科手术(全髋关节置换术、全膝关节置换术、开胸手术、乳房切除术和肿块切除术)后的阿片类药物使用情况。主要终点是阿片类药物停用时间。对BDI-II进行探索性因素分析后,计算每个识别出的因素的平均总分。使用Cox比例风险回归将这些分数作为阿片类药物停用时间的预测指标进行评估。
探索性因素分析产生了三个因素(自我厌恶症状、动机症状、情绪症状)。在单变量分析中,所有三个因素都是显著的预测指标。在BDI-II识别出的三个因素中,在多变量分析中,只有术前自我厌恶症状(过去的失败、内疚感、自我厌恶、自我批评、自杀念头、无价值感)独立预测术后阿片类药物停用率显著降低(风险比0.86,95%置信区间0.75-0.99,P值0.037)。
我们的结果确定了一组预测术后阿片类药物停用时间延长的负面认知。BDI-II所涵盖的躯体症状并非术前BDI-II得分与术后阿片类药物使用延长之间关联的主要原因。